Apoptosis of human primary osteoclasts treated with molecules targeting nuclear factor-κB

Annals of the New York Academy of Sciences

Volumn 1171, Issue , 2009, Pages 448-456

  Piva, Roberta ^a   Penolazzi, Letizia ^a   Borgatti, Monica ^a   Lampronti, Ilaria ^a   Lambertini, Elisabetta ^a   Torreggiani, Elena ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Apoptosis; Emblica officinalis; Medicinal plants; Osteoclast; Osteoporosis; Rheumatoid arthritis

Indexed keywords

AEGLE MARMELOS EXTRACT; ARGEMONE OIL; BIM PROTEIN; CASPASE 3; CNIDIUM MONNIERI EXTRACT; DIOSCOREA SPONGIOSA EXTRACT; EMBLICA OFFICINALIS EXTRACT; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LAGERSTROEMIA SPECIOSA EXTRACT; NATURAL PRODUCT; OLIGONUCLEOTIDE; PLANT EXTRACT; POLYALTHIA LONGIFOLIA EXTRACT; PROTEIN BCL 2; PROTEIN BCL XL; PSORALEA CORYLIFOLIA EXTRACT; SURVIVIN; UNCLASSIFIED DRUG; VERNONIA ANTHELMINTICA EXTRACT;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; BINDING COMPETITION; BLOOD; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; DNA SEQUENCE; DRUG POTENCY; DYSLIPIDEMIA; EXPERIMENTAL STUDY; GEL MOBILITY SHIFT ASSAY; GENE TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER PROTECTION; MUTAGENESIS; NONHUMAN; OSTEOCLAST; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

PHYLLANTHUS EMBLICA;

EID: 69149105914     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04906.x     Document Type: Conference Paper

References (33)

1. Szekanecz, Z. A.E. Koch. 2007. Macrophages and their products in rheumatoid arthritis. Curr. Opin. Rheumatol. 19 : 289 295.
2. Hadjidakis, D.J. I.I. Androulakis. 2006. Bone remodeling. Ann. N. Y. Acad. Sci. 1092 : 385 396.
3. Giuliani, N., F. Morandi, S. Tagliaferri V. Rizzoli. 2006. Targeting pathways mediating bone disease. Curr. Pharm. Biotechnol. 7 : 423 429.
4. Blair, H.C. M. Zaidi. 2006. Osteoclastic differentiation and function regulated by old and new pathways. Rev. Endocr. Metab. Disord. 7 : 23 32.
5. Penolazzi, L., E. Lambertini, M. Borgatti, et al. 2003. Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem. Pharmacol. 66 : 1189 1198.
6. Piva, R., L. Penolazzi, E. Lambertini, et al. 2005. Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha. Apoptosis 10 : 1079 1094.
7. Piva, R., L. Penolazzi, M. Zennaro, et al. 2006. Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules. Ann. N. Y. Acad. Sci. 1091 : 509 516.
8. Penolazzi, L., E. Magri, E. Lambertini, et al. 2006. Local in vivo administration of a decoy oligonucleotide targeting NF-kappaB induces apoptosis of osteoclasts after application of orthodontic forces to rat teeth. Int. J. Mol. Med. 18 : 807 811.
9. Piva, R., L. Penolazzi, E. Lambertini, et al. 2005. Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha. Apoptosis 10 : 1079 1094.
10. Matsuzaki, K., K. Katayama, Y. Takahashi, et al. 1999. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Endocrinology 140 : 925 932.
11. Akiyama, T., P. Bouillet, T. Miyazaki, et al. 2003. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22 : 6653 6664.
12. Strasser, A., L. O'Connor V.M. Dixit. 2000. Apoptosis signaling. Annu. Rev. Biochem. 69 : 217 245.
13. Sevilla, L., A. Zaldumbide, F. Carlotti, et al. 2001. Bcl-XL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU.1. J. Biol. Chem. 276 : 17800 17807.
14. Tamm, I., Y. Wang, E. Sausville, et al. 1998. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58 : 5315 5320.
15. Putnam, S.E., A.M. Scutt, K. Bicknell, et al. 2007. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother. Res. 21 : 99 112.
16. New, S.A. 2003. Intake of fruit and vegetables: implications for bone health. Proc. Nutr. Soc. 62 : 889 899.
17. Hidaka, S., Y. Okamoto, Y. Yamada, et al. 1999. A: Japanese herbal medicine, Chujo-to, has a beneficial effect on osteoporosis in rats. Phytother. Res. 13 : 14 19.
18. Funk, J.L., J.N. Oyarzo, J.B. Frye, et al. 2006. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J. Nat. Prod. 69 : 351 355.
19. Ramprasath, V.R., P. Shanthi P. Sachdanandam. 2006. Curative effect of Semecarpus anacardium Linn. nut milk extract against adjuvant arthritis - with special reference to bone metabolism. Chem. Biol. Interact. 160 : 183 192.
20. Sohail, M.T., M.I. Chaudhry, M.K. Usman, et al. 2005. Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders. Phytother. Res. 19 : 365 368.
21. Yin, J., Y. Tezuka, K. Kouda, et al. 2004. Antiosteporotic activity of the water extract of Dioscorea spongiosa. Biol. Pharm. Bull. 27 : 583 586.
22. Wang, D., F. Li Z. Jiang. 2001. Osteoblastic proliferation stimulating activity of Psoralea corylifollia extracts and two of its flavonoids. Planta Med. 67 : 748 749.
23. Meng, F., Z. Xiong, Y. Sun F. Li. 2004. Coumarins from Cidium monnieri (L.) and their proliferation stimulating activity on osteoblast-like UMR106 cells. Pharmazie 59 : 643 645.
24. Anila, L. N.R. Vijayalakshmi. 2002. Flavonoids from Emblica officinalis and Mangifera indica, effectiveness for dyslipidemia J. Ethnopharmacol. 79 81 87.
25. Thakur, C.P. K. Mandal. 1984. Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits Indian. J. Med. Res. 79 : 142 146.
26. Bhattacharya, A., M. Kumar, S. Ghosal S.K. Bhattacharya. 2000. Effect of bioactive tannoid principles of Emblica officinalis on iron-indued hepatic toxicity in rats. Phytomedicine 7 : 173 175.
27. Ahmad, I., Z. Mehmood F. Mohammad. 1998. Screening of some Indian medicinal plants for their antimicrobial properties. J. Ethnopharmacol. 62 : 183 193.
28. Asmawi, M.Z., H. Kankaanranta, E. Moilanen H. Vapaatalo. 1993. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J. Pharm. Pharmacol. 45 : 581 584.
29. Jeena, K.J., G. Kuttan R. Kuttan. 2001. Antitumor activity of Emblica officinalis. J. Ethnoph. 75 : 65 69.
30. Sancheti, G., A. Jindal, R. Kumari P.K. Goyal. 2005. Chemopreventive action of Emblica officinalis on skin carcinogenesis in mice. Asian Pac. J. Cancer Prev. 6 : 197 201.
31. Sultana, S., S. Ahmad, N. Khan T. Jahangir. 2005. Effect of Emblica officinalis (Gaertn) on CCl4 induced hepatic toxicity and DNA synthesis in Wistar rats. Indian J. Exp. Biol. 43 : 430 436.
32. Scartezzini, P., F. Antognoni, M.A. Raggi, et al. 2006. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. J. Ethnopharmacol. 104 : 113 118.
33. Lampronti, I., M.T.H. Khan, M. Borgatti, et al. Inhibitory effects of Bangladeshi medicinal plant extracts on interactions between transcription factors and target DNA sequences. Evid. Based Complement Alternat. Med. 5 : 303 312.